HuR stabilizes HTT mRNA via interacting with its exon 11 in a mutant HTT-dependent manner

RNA Biol. 2020 Apr;17(4):500-516. doi: 10.1080/15476286.2020.1712894. Epub 2020 Jan 13.

Abstract

Huntington's Disease (HD) is a monogenetic neurodegenerative disorder mainly caused by the cytotoxicity of the mutant HTT protein (mHTT) encoded by the mutant HTT gene. Lowering HTT mRNA has been extensively studied as a potential therapeutic strategy, but how its level is regulated endogenously has been unclear. Here we report that the RNA-binding protein (RBP) HuR interacts with and stabilizes HTT mRNA in an mHTT-dependent manner. In HD cells but not wild-type cells, siRNA knockdown or CRISPR-induced heterozygous knockout of HuR decreased HTT mRNA stability. HuR interacted with HTT mRNA at a conserved site in exon 11 rather than the 3'-UTR region of the mRNA. Interestingly, this interaction was dependent on the presence of mHTT, likely via the activation of MAPK11, which enhanced cytosolic localization of the HuR protein. Thus, mHTT, MAPK11 and HuR may form a positive feedback loop that stabilizes HTT mRNA and enhances mHTT accumulation, which may contribute to HD progression. Our data reveal a novel regulatory mechanism of HTT mRNA via non-canonical binding of HuR.

Keywords: CAG repeats; Huntington’s disease; MAPK; RNA binding protein; neurodegeneration; p38; polyglutamine.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • 3' Untranslated Regions
  • Animals
  • Binding Sites
  • CRISPR-Cas Systems
  • Cell Line
  • ELAV-Like Protein 1 / genetics
  • ELAV-Like Protein 1 / metabolism*
  • Exons
  • Feedback, Physiological
  • Gene Knockdown Techniques
  • HEK293 Cells
  • Humans
  • Huntingtin Protein / chemistry*
  • Huntingtin Protein / genetics*
  • Huntington Disease / genetics*
  • Huntington Disease / metabolism
  • Mice
  • Mitogen-Activated Protein Kinase 11 / metabolism*
  • Mutation*
  • RNA Stability

Substances

  • 3' Untranslated Regions
  • ELAV-Like Protein 1
  • ELAVL1 protein, human
  • HTT protein, human
  • Huntingtin Protein
  • Mitogen-Activated Protein Kinase 11

Grants and funding

Project Supported by National Natural Science Foundation of China [31970747, 31601105, 81870990, 81925012], Science and Technology Commission of Shanghai Municipality [18410722100], Shanghai Municipal Science and Technology Major Project [No.2018SHZDZX01] and ZJLab, and Hereditary Disease Foundation for funding supports. Funding for open access charge: National Natural Science Foundation of China.